Goodrx Holdings Inc Net Assets
Goodrx Holdings Inc net assets. Based on the latest financial reports, Goodrx Holdings Inc (GDRX) has net assets worth $600.71 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.33 Billion) and total liabilities ($724.79 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Goodrx Holdings Inc equity growth rate to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $600.71 Million |
| % of Total Assets | 45.32% |
| Annual Growth Rate | 14.25% |
| 5-Year Change | 1.87% |
| 10-Year Change | N/A |
| Growth Volatility | 322.17 |
Net Assets of Goodrx Holdings Inc (2016–2024)
Net assets of Goodrx Holdings Inc from 2016 to 2024. This chart illustrates how Goodrx Holdings Inc's net assets have evolved over time, based on quarterly financial data. See GDRX equity financing ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Goodrx Holdings Inc (2016–2024)
The table below shows the annual net assets of Goodrx Holdings Inc from 2016 to 2024. For live market cap and overall valuation, see Goodrx Holdings Inc stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $724.66 Million | -4.90% |
| 2023-12-31 | $761.96 Million | -6.49% |
| 2022-12-31 | $814.83 Million | -2.03% |
| 2021-12-31 | $831.68 Million | +16.91% |
| 2020-12-31 | $711.36 Million | +165.41% |
| 2019-12-31 | $-1.09 Billion | +6.44% |
| 2018-12-31 | $-1.16 Billion | -870.52% |
| 2017-12-31 | $150.86 Million | -39.55% |
| 2016-12-31 | $249.57 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Goodrx Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 17870.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Goodrx Holdings Inc Net Assets Breakdown (December 2024)
Goodrx Holdings Inc net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $38.00K | 0.01% |
| Other Components | $2.17 Billion | 298.85% |
| Total Equity | $724.66 Million | 100.00% |
Goodrx Holdings Inc Competitors by Market Cap
The table below lists competitors of Goodrx Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zhejiang Jinsheng New Materials Co
SHE:300849
|
$392.46 Million |
|
Suzhou Longjie Special Fiber Co Ltd
SHG:603332
|
$392.56 Million |
|
Tupy S.A
SA:TUPY3
|
$392.75 Million |
|
Chang Lan Electric Technology Co Ltd
SHE:002879
|
$392.78 Million |
|
Blue Label Telecoms Ltd
JSE:BLU
|
$392.27 Million |
|
HOMAG Group AG
F:HG1
|
$392.20 Million |
|
Ipd Group Ltd
AU:IPG
|
$392.14 Million |
|
Korea SPAC 3
KQ:222080
|
$392.12 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Goodrx Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 761,958,000 to 724,658,000, a change of -37,300,000 (-4.9%).
- Net income of 16,390,000 contributed positively to equity growth.
- Share repurchases of 158,845,000 reduced equity.
- Other factors increased equity by 105,155,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $16.39 Million | +2.26% |
| Share Repurchases | $158.84 Million | -21.92% |
| Other Changes | $105.16 Million | +14.51% |
| Total Change | $- | -4.90% |
Book Value vs Market Value Analysis
This analysis compares Goodrx Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.01x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 176.79x to 2.01x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $0.02 | $3.72 | x |
| 2017-12-31 | $-0.22 | $3.72 | x |
| 2018-12-31 | $-3.21 | $3.72 | x |
| 2019-12-31 | $-3.00 | $3.72 | x |
| 2020-12-31 | $2.59 | $3.72 | x |
| 2021-12-31 | $2.03 | $3.72 | x |
| 2022-12-31 | $1.97 | $3.72 | x |
| 2023-12-31 | $1.86 | $3.72 | x |
| 2024-12-31 | $1.85 | $3.72 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Goodrx Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.26%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.07%
- • Asset Turnover: 0.57x
- • Equity Multiplier: 1.92x
- Recent ROE (2.26%) is above the historical average (-15.90%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -95.87% | -7.82% | 0.34x | 36.46x | $-8.58 Million |
| 2017 | 0.00% | 5.62% | 0.55x | 0.00x | $17.46 Million |
| 2018 | 0.00% | 17.55% | 0.79x | 0.00x | $160.04 Million |
| 2019 | 0.00% | 17.01% | 1.00x | 0.00x | $174.81 Million |
| 2020 | -41.28% | -53.32% | 0.37x | 2.10x | $-364.76 Million |
| 2021 | -3.04% | -3.39% | 0.46x | 1.93x | $-108.42 Million |
| 2022 | -4.03% | -4.28% | 0.48x | 1.97x | $-114.31 Million |
| 2023 | -1.16% | -1.18% | 0.47x | 2.09x | $-85.06 Million |
| 2024 | 2.26% | 2.07% | 0.57x | 1.92x | $-56.08 Million |
Industry Comparison
This section compares Goodrx Holdings Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $347,641,116
- Average return on equity (ROE) among peers: -121.12%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Goodrx Holdings Inc (GDRX) | $600.71 Million | -95.87% | 1.21x | $392.34 Million |
| Aclarion Inc (ACON) | $-728.00K | 0.00% | 0.00x | $1.01 Million |
| American Well Corp (AMWL) | $1.26 Billion | -13.99% | 0.15x | $133.17 Million |
| Heartbeam Inc (BEAT) | $1.65 Million | -1175.82% | 0.98x | $23.90 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $4.96 Million | -140.89% | 0.12x | $6.00 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $1.89 Billion | 10.11% | 2.40x | $10.63 Billion |
| Carlsmed, Inc. (CARL) | $-46.13 Million | 0.00% | 0.00x | $409.27 Million |
| CareCloud, Inc. (CCLD) | $38.87 Million | -5.50% | 0.23x | $76.49 Million |
| Certara Inc (CERT) | $492.77 Million | -6.75% | 1.13x | $1.12 Billion |
| CareMax Inc (CMAX) | $4.95 Million | 121.69% | 3.92x | $381.50 |
| Claritev Corporation (CTEV) | $-167.18 Million | 0.00% | 0.00x | $369.43 Million |
About Goodrx Holdings Inc
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products … Read more